Latent profile analysis of stigma and medical coping among patients with vaginitis: a cross-sectional study Authors: Yingshi Li, Li Yuan, Zhijia Zhang, Song Li, Qihua Huang Published: 2026 ABSTRACT AbstractBackgroundVaginitis is a common chronic condition among genital tract infections. Its sensitive anatomical location and tendency to recur not only impact individual health but also affect psychological well-being and coping strategies. This study aimed to identify latent profiles of stigma and medical coping among patients with vaginitis and to examine their associated factors, providing evidence for tailored health education.MethodsPatients with vaginitis attending a gynecology clinic between January and March 2024 were recruited. Data were collected using the General Information Questionnaire, Social Impact Scale (SIS), Medical Coping Questionnaire (MCMQ), and Perceived Social Support Scale (PSSS). Latent profile analysis was conducted to identify subgroups based on stigma and coping patterns, and associated factors were examined using univariate analyses and multinomial logistic regression. This study was approved by the Research Ethics Committee of Guangdong Provincial Hospital of Traditional Chinese Medicine, and informed consent was obtained from all participants.ResultsA total of 211 patients with vaginitis were included in this study. Their average SIS score was 52.22 ± 12.27, and their average PSSS score was 56.67 ± 12.00. Based on both stigma and medical coping strategies, three latent profiles were identified: Low Stigma–Active Coping Group (25.1%), Moderate Stigma–Conventional Coping Group (58.8%), and High Stigma–Negative Coping Group (16.1%). Multivariable logistic regression analysis showed that, using the Low Stigma–Active Coping Group as the reference category, unemployment was a risk factor for membership in the Moderate Stigma–Conventional Coping Group (OR = 2.909) and the High Stigma–Negative Coping Group (OR = 6.266). Having a “basic understanding” of vaginitis (OR = 0.072) and higher social support (OR = 0.960) were protective factors for membership in the Moderate Stigma–Conventional Coping Group. Age < 46 years (18–24 years: OR = 0.025; 25–35 years: OR = 0.028; 36–45 years: OR = 0.026), having a “basic” or “partial” understanding of vaginitis (OR = 0.042; OR = 0.065), and perceived social support (OR = 0.889) were protective factors against membership in the High Stigma–Negative Coping Group (P < 0.05).ConclusionsPatients with vaginitis exhibit heterogeneity in their experiences of stigmatization and medical coping strategies. Based on the distinct stigma and coping profiles identified in this study, healthcare professionals should implement targeted interventions. These interventions could help to reduce stigma levels and encourage positive coping strategies among patients with vaginitis. However, this study is limited by its cross-sectional design and single-center setting, and future multicenter and longitudinal studies are warranted to further validate these findings.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s12905-026-04653-2.Keywords: Health education, Latent profile analysis, Medical coping, Stigma, Vaginitis Introduction Vaginitis is one of the most common infections of the female reproductive tract among women of reproductive age. Epidemiological studies suggest that approximately 20%–50% of women experience vaginitis, with recurrence rates ranging from 30% to 50% [1]. In China, an estimated 340 million women suffer from reproductive tract disorders [2], and vaginitis accounts for more than 40% of gynecological outpatient visits [1]. These figures underscore the substantial public health burden of vaginitis and highlight the need for more effective and targeted interventions. Vaginitis is a broad term encompassing vaginal disorders caused by infection, inflammation, or dysbiosis of the normal microbiota. It is typically classified as either infectious or non-infectious [3], with infectious vaginitis accounting for 70%–90% of cases, including bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis. In contrast, non-infectious vaginitis predominantly stems from vaginal atrophy secondary to decreased estrogen levels, commonly referred to as atrophic vaginitis. Due to its anatomical location and recurrent nature, vaginitis is often accompanied by distressing symptoms such as pruritus, abnormal discharge, and dyspareunia [4]. If left untreated or poorly managed, vaginitis may lead to pelvic inflammatory disease and tubal obstruction, potentially predisposing patients to infertility and adverse pregnancy outcomes. In addition, these complications can significantly impair daily functioning, sexual health, and psychological well-being [5–7]. The sociocultural sensitivity surrounding women’s reproductive health, combined with limited disease-related knowledge [8], may impose an additional psychological burden. Consequently, many women with vaginal infections experience confusion, shame, or stigma [8]. Stigma refers to the devaluation or social discredit associated with a particular condition and is often manifested as perceived discrimination, social distancing, and internalized shame [9]. In the Chinese sociocultural context, discussions of sexual and reproductive health remain relatively private, and women may be reluctant to disclose related concerns, even to healthcare professionals [10]. Vaginal infections are often socially associated with sexual activity, which can evoke negative social judgments and reinforce stigmatizing attitudes [11]. Empirical studies indicate that women with vaginitis report higher levels of anxiety and depression compared with those without the condition [12]. In addition to psychological distress, the management of vaginitis can impose a financial burden [13]. Together, these factors may delay healthcare-seeking, reduce treatment adherence, and ultimately compromise quality of life [5, 14, 15]. Between 50% and 80% of individuals with chronic conditions experience varying degrees of stigma, often accompanied by anxiety and depression [16–18]. The extent of stigma is shaped by multiple factors, including sociodemographic characteristics, disease attributes, and social support [19, 20]. In China, research on stigma interventions remains limited and is largely focused on cognitive or multimodal approaches. However, these interventions often adopt a one-size-fits-all framework and fail to account for individual heterogeneity in stigma experiences, coping behaviors, and available social resources. Moreover, existing research has primarily concentrated on conditions such as mental illness [21], HIV/AIDS [22], cancer [23], and obesity [24], whereas stigma among women with vaginitis has received comparatively little attention, particularly in underdeveloped regions [4]. This gap highlights the need for more nuanced, population-specific investigations. Women may be particularly vulnerable to psychological distress when facing illness, with many reporting elevated levels of stress related to both the disease and its treatment [25]. This may manifest as depression, anxiety, and heightened emotional sensitivity [26]. Illness-related shame can also influence the coping strategies individuals adopt [27]. Coping refers to the cognitive and behavioral efforts used to manage internal and external demands associated with stress [28]. These strategies are commonly categorized as active or maladaptive. Active coping involves problem-solving, information-seeking, and seeking social support, whereas maladaptive coping is characterized by avoidance, denial, and social withdrawal [29]. Previous research suggests a close relationship between coping styles and stigma [30]. Active coping enables patients to develop a clearer understanding of their condition and to proactively seek medical care and social support, thereby mitigating perceived stigma [31]. By contrast, reliance on negative coping strategies often leads patients to conceal their condition, avoid medical treatment, and reduce social interaction [30]. Such maladaptive behaviors not only fail to alleviate stigma but may also exacerbate self-doubt and social isolation, creating a reinforcing cycle of increased stigma and negative coping. From a theoretical perspective, Link and Phelan’s stigma framework [32] and cognitive-behavioral theory (CBT) offer complementary perspectives for understanding the relationship between stigma and coping styles among patients with vaginitis. The stigma framework emphasizes that stigma is not merely an individual psychological experience but a socially constructed process. Specifically, the social environment in which individuals live shapes their illness-related cognitions and behavioral responses. Among patients with vaginitis, negative societal judgments may be internalized, leading to internalized shame and social isolation. However, the stigma framework primarily explains the origins and social construction of stigma. Cognitive-behavioral theory complements this perspective by explaining why patients with the same condition may adopt different coping strategies. According to CBT [33], emotional and behavioral responses are not determined directly by external events; rather, they are mediated by individuals’ cognitive appraisals of those events. In other words, patients do not passively accept stigmatizing societal attitudes toward vaginitis. Instead, they interpret such social information through their own illness-related cognitive appraisals (e.g., whether they attribute the condition to personal fault, anticipate discrimination, or perceive the condition as controllable) [34], which in turn shape their emotional experiences and behavioral responses. Importantly, stigma and coping styles do not exist in isolation. Rather, they are theoretically and empirically interconnected, forming a mutually reinforcing process that shapes a patient’s overall psychosocial adaptation to vaginitis. Examining these constructs separately through independent latent profile analyses or traditional variable-centered approaches (e.g., correlation or regression), risks artificially decoupling intrinsically linked phenomena. This approach also fails to capture the ways in which different combinations of stigma and coping patterns cluster within individuals. Latent Profile Analysis (LPA) [35] is a person-centered statistical method that examines latent relationships among observed variables to classify individuals into groups with similar characteristics. Incorporating both stigma and coping constructs within a single LPA model provides several advantages over traditional variable-centered approaches: (1) it reveals how stigma and coping co-occur heterogeneously at the individual level; (2) it generates a clinically actionable typology that reflects patients’ real-world psychosocial profiles; and (3) it enables targeted, profile-specific interventions aimed at simultaneously reducing stigma and promoting adaptive coping. Therefore, this study aimed to identify distinct stigma–coping profiles among women with vaginitis using latent profile analysis and to examine factors associated with profile categories. By elucidating heterogeneity in stigma–coping patterns, the findings aim to inform more targeted and personalized intervention strategies. Methods Study design and participants This study employed a cross-sectional design to assess participants’ levels of stigma and coping strategies at a single time point and to identify latent subgroups using latent profile analysis (LPA). A cross-sectional approach is appropriate for LPA when the aim is to explore population heterogeneity and identify distinct profiles rather than to examine causal relationships or changes over time. It adhered to the STROBE reporting guidelines. From January to March 2024, participants were recruited using convenience sampling from patients with vaginitis attending the gynecology outpatient department of a tertiary hospital in Guangdong Province, China. The inclusion criteria were as follows: (1) age ≥ 18 years; (2) a confirmed diagnosis of vaginitis based on standardized diagnostic guidelines [1]: ①Vulvovaginal candidiasis (VVC): diagnosis confirmed if budding spores or pseudohyphae of Candida were identified during microscopic examination of vaginal discharge. ②Bacterial vaginosis (BV): three of the following four criteria must be met, with a positive clue cell test being mandatory: Ⅰ. The vaginal discharge is uniform in consistency, thin, and greyish-white in color. Ⅱ. Vaginal fluid pH > 4.5. Ⅲ. Positive whiff test. Ⅳ. Presence of clue cells. ③Aerobic vaginitis (AV): Combined diagnostic criteria for aerobic vaginitis based on Gram stain smears and clinical features, a score of ≥ 4 is sufficient for diagnosis. ④Vaginal trichomoniasis: The vaginal discharge is thin, purulent, and frothy, with an unpleasant odor, and Trichomonas has been detected in the discharge. ⑤Mixed vaginitis: For the four common types of vaginitis (BV, AV, VVC, and vaginal trichomoniasis), the presence of at least two pathogens or the fulfilment of the diagnostic criteria for two or more types of vaginitis; (3) provision of informed consent and voluntary participation. The exclusion criteria included: (1) severe heart, lung, liver, or kidney disease; (2) individuals with a history of mental illness, such as those with a past or current diagnosis of schizophrenia, bipolar disorder, cognitive impairment, etc.; (3) individuals with communication barriers. These conditions were assessed based on medical records and patient self-report at the time of recruitment. According to Kendall’s sample-size estimation principle, the minimum sample size should be at least 5–10 times the number of study variables. This study involved 19 independent variables (nine demographic scales and ten scale-measured variables), resulting in a minimum requirement of 95–190 cases. Taking potential invalid responses into account (estimated at 20%), the required sample size was increased by 20%, meaning the minimum required for this study was 114 cases. When fitting latent profile models, the Bayesian Information Criterion (BIC) was used as the primary criterion for model selection, and a minimum sample size of 200 participants was required [36]. From the 220 questionnaires initially issued, we retrieved 211 usable datasets, representing a 95% valid response rate. Measures General information questionnaire This instrument was used to collect characteristic sociodemographic data designed by members of the research team. These items included age, employment status, education level, sexual life, marital status, residence, monthly income, infection type, and knowledge of vaginitis. (Supplementary file 1) Measurement of stigma The Chinese version of the Social Impact Scale (SIS) was employed to quantify disease-related stigma. Originally developed by Fife [37] in 2000 and later adapted into Chinese by Pan (2007) [38], this standardized instrument is widely utilized across various clinical populations. The scale comprises 24 items organized into four dimensions: social exclusion (9 items), economic discrimination (3 items), internal shame (5 items), and social isolation (7 items). Each item is rated on a 4-point Likert scale, ranging from 1 (strongly disagree) to 4 (strongly agree). Total scores range from 24 to 96, with higher values reflecting a greater perceived stigma burden. While the Chinese version has demonstrated robust psychometric properties in previous validation studies [38] (e.g., internal consistency of 0.99), the Cronbach’s α in the present study was 0.946, confirming excellent internal reliability. Measurement of medical coping styles The Chinese version of the Medical Coping Questionnaire (MCMQ) was utilized to evaluate patients’ coping strategies. Originally developed by Feifel H [39] and later validated for the Chinese population by Shen et al. [40], this 20-item instrument assesses three distinct dimensions of coping: Confrontation (8 items), Avoidance (7 items), and Resignation (5 items). Items are scored on a 4-point Likert scale, ranging from 1 (strongly disagree) to 4 (strongly agree). In its initial validation, the revised Chinese version demonstrated acceptable psychometric properties, with Cronbach’s α coefficients for the three subscales reported at 0.69, 0.60, and 0.76, respectively, and three-week test-retest reliabilities of 0.64, 0.85, and 0.67. In the present study, the scale showed favorable internal consistency, with an overall Cronbach’s α of 0.732. Measurement of social support The Perceived Social Support Scale (PSSS), originally developed by Zimet et al. [41] and later culturally adapted for the Chinese context by Jiang (2001) [42], was used to measure patients’ subjective perceptions of social support. This 12-item instrument evaluates three distinct domains: family support (items 3, 4, 8, and 11), friend support (items 6, 7, 9, and 12), and other support (items 1, 2, 5, and 10). Each item is scored on a 7-point Likert scale, ranging from 1 (strongly disagree) to 7 (strongly agree). The Chinese version of the PSSS has demonstrated robust psychometric properties across diverse populations, with reported Cronbach’s α coefficients exceeding 0.70 for all dimensions and 0.84 for the overall scale. In the current study, the instrument exhibited excellent internal reliability, with a Cronbach’s α of 0.946. Data collection and quality control Before study initiation, all investigators completed a rigorous training program to standardize recruitment and data handling protocols. Potential participants were identified and briefed on the research scope and significance; written informed consent was obtained from all who agreed to join. To safeguard privacy, the data collection remained strictly anonymous. Surveys were administered on-site post-consultation, with patients accessing the digital questionnaire via a unique QR code on the Wenjuanxing platform (https://www.wjx.cn/). Completion of the self-report tool typically spanned 15 to 20 min. We enforced several safeguards to bolster data quality: IP addresses were restricted to single submissions, and any record reflecting patterned responses or an improbable completion time (under five minutes) was discarded. Statistical analysis Latent profile analysis was conducted using Mplus version 8.3, following the guidelines proposed by Tein et al. [43] and Sinha et al. [44]. The four dimensions of the Social Impact Scale and the three dimensions of the Medical Coping Questionnaire were specified as manifest indicators and incorporated into the models. Models with increasing numbers of latent profiles were estimated sequentially. Model fit was evaluated using multiple indices: (1) the Akaike Information Criterion (AIC), Bayesian Information Criterion (BIC), and sample-sized adjusted BIC (aBIC), with lower values indicating better model fit; (2) entropy, with values closer to 1 reflecting higher classification accuracy, and values ≥ 0.80 indicating acceptable classification precision; and (3) the Lo-Mendell-Rubin likelihood ratio test (LMRT) and the bootstrapped likelihood ratio test (BLRT), which compare models with k and k − 1 classes, where a P-value < 0.05 suggests that the k-class model provides a significantly better fit. The optimal number of latent profiles was determined based on a combination of statistical fit indices and the interpretability and practical relevance of the model. Data analysis was conducted using IBM SPSS Statistics (version 27.0). Categorical data were summarized as frequencies and percentages, while continuous variables were expressed as mean ± standard deviation (SD) for normally distributed data, or as median (M) and interquartile range (IQR) for skewed distributions. To compare demographic and clinical characteristics across the identified latent profiles, Chi-square tests or Kruskal-Wallis H tests were employed where appropriate. Variables with statistical significance in univariate analyses were included in the multinomial logistic regression model to reduce model complexity and minimize the risk of overfitting given the sample size. The potential influence of confounding factors was also considered when interpreting the results. Multinomial logistic regression was then performed to identify factors associated with latent profile categories. All statistical tests were two-tailed, with the significance threshold established at P < 0.05. Ethical consideration This study was conducted in accordance with the guidelines of the Declaration of Helsinki and received approval from the Research Ethics Committee of Guangdong Provincial Hospital of Traditional Chinese Medicine (No. BF2022–130–01). The study adhered to the principle of voluntary participation. To ensure privacy, the questionnaire was anonymous, and all participants provided informed consent. Results Demographic characteristics of participants and current status of stigma and medical coping styles A total of 211 patients with vaginitis participated in this study. The participants’ ages ranged from 18 to 60 years, with a mean age of 34.27 ± 8.60 years. Socio-demographically, the majority were married (64.0%), employed (63.0%), and earned a monthly income of less than 10,000 RMB, while 39.8% held a bachelor’s degree or higher. More details can be found in Table 3. Table 1Univariate analysis of sociodemographic and clinical characteristics across latent stigma–coping profiles among patients with vaginitis (N = 211)VariableTotal (n = 211)C1 (n = 53)C2 (n = 124)C3 (n = 34)/F P Age (years)27.580a)< 0.001 18–2417(8.1%)5(9.4%)10(8.1%)2(5.9%) 25–35113(53.6%)30(56.6%)72(58.1%)11(32.4%) 36–4556(26.5%)17(32.1%)32(25.8%)14(20.6%) ≥ 4625(11.8%)1(1.9%)10(8.1%)14(41.2%)34.27 ± 8.60Employment status12.995a)0.002 Unemployed78(37.0%)11(20.8%)47(37.9%)20(58.8%) Employed133(63.0%)42(79.2%)75(62.1%)14(41.2%)Education level26.930a)< 0.001 Junior high school or below36(17.1%)3(5.7%)21(16.9%)12(35.3%) Senior high/secondary technical school40(18.9%)4(7.5%)29(23.4%)7(20.6%) Three-year college51(24.2%)17(32.1%)24(19.4%)10(29.4%) Bachelor degree or above84(39.8%)29(54.7%)50(40.3%)5(14.7%)Sexual life1.780a)0.415 No15(7.1%)4(7.5%)7(5.6%)4(11.8%) Yes206(92.9%)49(92.5%)117(94.4%)30(88.2%)Marital status8.290a)0.060 Married135(64.0%)26(49.1%)83(66.9%)26(76.5%) Unmarried70(33.1%)25(47.2%)38(30.6%)7(20.6%) Divorce6(2.9%)2(3.8%)3(2.4%)1(2.9%)Residence1.230a)0.568 Urban196(92.9%)51(96.2%)114(91.9%)31(91.2%) Rural15(7.1%)2(3.8%)10(8.1%)3(8.8%)Monthly income (RMB per person per month)11.780a)0.019 < 500081(38.4%)13(24.5%)48(38.7%)20(58.8%) 5000–10,000102(48.3%)29(54.7%)61(49.2%)12(35.3%) > 10,00028(13.3%)11(20.8%)15(12.1%)2(5.9%)Infection type6.256a)0.369 Mixed vaginitis7(3.3%)1(1.9%)3(2.4%)3(8.8%) Vulvovaginal candidiasis132(62.6%)36(67.8%)76(61.3%)20(58.8%) Bacterial vaginosis51(24.2%)11(20.8%)30(24.2%)10(29.4%) Vaginal trichomoniasis21(10.0%)5(9.4%)15(12.1%)1(2.9%)Knowledge of vaginitis42.736a)< 0.001 Basic understanding49(23.2%)24(45.3%)18(14.8%)7(20.6%) Partial understanding104(49.2%)25(47.2%)72(58.1%)7(20.6%) No understanding58(27.6%)4(7.5%)34(27.4%)20(58.8%)Perceived Social Support Scale(M ± SD)-63.23 ± 10.5556.42 ± 10.7547.35 ± 12.2921.805b)< 0.001a = χ², b = F-value, C1 = Low Stigma–Active Coping Group, C2 = Moderate Stigma–Conventional Coping Group, C3 = High Stigma–Negative Coping Group Univariate analysis of sociodemographic and clinical characteristics across latent stigma–coping profiles among patients with vaginitis (N = 211) Perceived Social Support Scale (M ± SD) a = χ², b = F-value, C1 = Low Stigma–Active Coping Group, C2 = Moderate Stigma–Conventional Coping Group, C3 = High Stigma–Negative Coping Group Regarding clinical assessments, the mean total scores for the SIS and PSSS were 52.22 ± 12.27 and 56.67 ± 12.00, respectively. In terms of medical coping styles, the dimensions of confrontation, avoidance, and resignation yielded scores of 18.41 ± 3.33, 15.16 ± 3.22, and 8.21 ± 3.21, respectively. Latent profile analysis of stigma and medical coping in patients with vaginitis Latent profile analysis was performed based on the four dimensions of the SIS and the three dimensions of the MCMQ, with models ranging from one to five classes evaluated. As summarized in Table 1, incremental increases in the number of classes led to a progressive decline in AIC, BIC, and aBIC values, while all entropy values remained above 0.8. Although the 4-class model yielded the highest entropy, its LMRT p-value failed to reach statistical significance (P > 0.05). In contrast, the 3-class model demonstrated superior overall performance; its AIC, BIC, and aBIC values were lower than those of the 2-class model, and it maintained a higher entropy. Furthermore, both LMRT and BLRT for the 3-class model were statistically significant (P < 0.05). Given that the smallest class comprised 16.1% of the total sample, this model provided a meaningful and distinct categorization of stigma levels and coping styles. Consequently, the 3-class model was identified as the optimal solution. The average posterior probabilities for class membership were 94.1%, 97.0%, and 94.8%, respectively, confirming the high classification reliability. Further details are provided in Table 2. Table 2Fit indices for latent profile models of stigma and medical coping among patients with vaginitis (N = 211)ModelAICBICaBICEntropyP-valueClass proportions (%)LMRTBLRT12462.2012509.1272464.76622213.5182287.2582217.5490.872< 0.01< 0.0172.5/ 27.5 3 2034.523 2135.079 2040.020 0.912 < 0.01 < 0.01 25.1/58.8/16.1 42000.0462127.4172007.0090.9200.40< 0.0122.7/56.4/18.5/2.451971.5192125.7041979.9480.9061.00< 0.0111.4/52.1/16.1/2.8/17.5AIC Akaike Information Criterion, BIC Bayesian Information Criterion, aBIC sample-sized adjusted Bayesian Information Criterion, LMRT Lo-Mendell-Rubin likelihood ratio test, BLRT Bootstrapped likelihood ratio testBold values indicate the selected latent profile model with the best balance between model fit indices, classification accuracy, statistical significance, and interpretability Fit indices for latent profile models of stigma and medical coping among patients with vaginitis (N = 211) AIC Akaike Information Criterion, BIC Bayesian Information Criterion, aBIC sample-sized adjusted Bayesian Information Criterion, LMRT Lo-Mendell-Rubin likelihood ratio test, BLRT Bootstrapped likelihood ratio test Bold values indicate the selected latent profile model with the best balance between model fit indices, classification accuracy, statistical significance, and interpretability Table 3Classification probabilities for the three latent profiles of stigma and coping among patients with vaginitisClass12310.9410.0590.00020.0110.9700.02030.0000.0520.948 Classification probabilities for the three latent profiles of stigma and coping among patients with vaginitis Latent category characteristics and naming of stigma and medical coping in patients with vaginitis Based on Model 3, the distribution scores of the three categories in terms of stigma levels and medical coping styles are shown in Fig. 1. Based on scores across each dimension, the three categories were named as follows: Class 1 scored lowest on social exclusion, economic discrimination, internal shame, and social isolation, while scoring highest on confrontation, thus it was named ‘Low Stigma–Active Coping Group’, accounting for 25.1%. Class 3 scored highest on the SIS dimensions and highest on resignation, thus it was named ‘High Stigma–Negative Coping Group’, accounting for 16.1%. Participants in Class 2 scored moderately across all dimensions of the SIS and relatively evenly across all dimensions of the MCMQ, and exhibited an intermediate profile with no obvious extreme coping strategies and were therefore designated the ‘Moderate Stigma–Conventional Coping Group’, accounting for 58.8%. The latent profile distribution characteristics of stigma and medical coping in patients with vaginitis Univariate analysis of latent profile categories of stigma and medical coping in patients with vaginitis The results of the univariate analysis of potential factors influencing stigma and coping strategies among vaginitis patients are shown in Table 3. There were also statistically significant differences in age (χ² = 27.580, P < 0.001), employment status (χ² = 12.995, P = 0.002), education level (χ² = 26.930, P < 0.001), monthly income (χ² = 11.780, P = 0.019), knowledge of vaginitis (χ² = 42.736, P < 0.001), and perceived social support scale (F = 21.805, P < 0.001) among the three different patient groups. Multivariate logistic regression of potential profile categories of stigma and medical coping in patients with vaginitis Using the three latent profiles as the dependent variables and Class 1 (Low Stigma–Active Coping Group) as the reference group, we conducted a multivariate logistic regression analysis, incorporating the statistically significant indicators from Table 1 as independent variables (age, employment status, education level, monthly income, social support, and knowledge of vaginitis). The variable assignments are shown in Table 4. As shown in Table 5, unemployment was a risk factor for membership in Class 2 (Moderate Stigma–Conventional Coping Group) (OR = 2.909, P = 0.022), while a higher level of knowledge about vaginitis (Basic understanding: OR = 0.072, P < 0.001) and a higher PSSS score (OR = 0.960, P = 0.039) were protective factors. Regarding entry into Class 3 (High Stigma–Negative Coping Group), compared with those aged ≥ 46 years, being aged 18–24 (OR = 0.025, P = 0.020), 25–35 years (OR = 0.028, P = 0.007) and 36–45 years (OR = 0.026, P = 0.007) were less likely to belong to Class 3; unemployment was associated with increased odds of membership in Class 3 (OR = 6.266, P = 0.006); knowledge of vaginitis (Basic understanding: OR = 0.042, P < 0.001; Partial understanding: OR = 0.065, P < 0.001) and PSSS scores (OR = 0.889, P < 0.001) were negatively associated with entry into Class 3. Table 4Variable assignmentVariablesVariable assignmentAge18–24 = 1, 25–35 = 2, 36–45 = 3, ≥ 46 = 4Employment statusUnemployed = 1, Employed = 2Education levelJunior high school or below = 1,Senior high/secondary technical school = 2,Three-year college = 3,Bachelor degree or above = 4Monthly income (RMB per person per month)< 5000 = 1, 5000–10,000 = 2, > 10,000 = 3Knowledge of vaginitisBasic understanding = 1, Partial understanding = 2, No understanding = 3Perceived Social Support ScaleOriginal value Variable assignment Junior high school or below = 1, Senior high/secondary technical school = 2, Three-year college = 3, Bachelor degree or above = 4 Table 5Multinomial logistic regression analysis of factors associated with latent stigma–coping profiles among patients with vaginitis (reference: Low Stigma–Active Coping Group)VariablesModerate Stigma–Conventional Coping GroupHigh Stigma–Negative Coping GroupBOR95% CI P BOR95% CI P Age (Ref:≥46 years) 18–24-1.6210.1980.015–2.6580.221 -3.687 0.025 0.001–0.565 0.020 25–35-1.2960.2740.026–2.8390.278 -3.576 0.028 0.002–0.384 0.007 36–45-1.6570.1910.018–1.9710.164 -3.635 0.026 0.002–0.369 0.007 Employment status (Ref: Employed) Unemployed 1.068 2.909 1.163–7.278 0.022 1.835 6.266 1.713–22.917 0.006 Education level (Ref: Bachelor degree or above) Junior high school or below0.4101.5060.323–7.0350.6021.1003.0030.308–29.2570.344 Senior high/secondary technical school0.5691.7670.479–6.5250.3930.3221.3800.196–9.7130.746 Three-year college-0.4940.6100.249–1.5100.2860.9542.5960.564–11.9440.221Monthly income (RMB per person per month) (Ref:>10000) <50000.8432.3220.622–8.6710.2100.5911.8060.180–18.0690.615 5000–10,0000.7502.1180.707–6.3440.1801.2073.3440.430–25.9840.249Knowledge of vaginitis (Ref: No understanding) Basic understanding -2.633 0.072 0.019–0.274 < 0.001 -3.162 0.042 0.007–0.245 < 0.001 Partial understanding-0.9390.3910.117–1.3090.128 -2.730 0.065 0.013–0.321 < 0.001 Perceived Social Support (Ref: original value) -0.041 0.960 0.923–0.998 0.039 -0.118 0.889 0.837–0.944 < 0.001 95% CI = 95% confidence interval, OR Odds ratioBold values indicate statistically significant results (P < 0.05) Multinomial logistic regression analysis of factors associated with latent stigma–coping profiles among patients with vaginitis (reference: Low Stigma–Active Coping Group) 95% CI = 95% confidence interval, OR Odds ratio Bold values indicate statistically significant results (P < 0.05) Discussion Group heterogeneity in stigma and medical coping among patients with vaginitis The present study identified a moderate overall level of stigma among patients with vaginitis, with relatively higher scores observed in the domain of internalized shame. Perceived social support was also at a moderate level. To our knowledge, this is the first study to simultaneously examine stigma and coping patterns among patients with vaginitis in China using latent profile analysis. Three distinct latent profiles were identified: the Low Stigma–Active Coping Group, the Moderate Stigma–Conventional Coping Group, and the High Stigma–Negative Coping Group, highlighting substantial heterogeneity in patients’ psychosocial responses. In this study, the terminology used to describe coping patterns is based on the underlying dimensions of the Medical Coping Questionnaire. Active coping primarily refers to confrontational strategies, negative coping mainly includes avoidance and resignation, which are generally considered less adaptive, and conventional coping reflects a relatively balanced or transitional use of multiple coping strategies without a dominant pattern. The Low Stigma–Active Coping Group was characterized by minimal perceived stigma and a strong tendency toward confrontational coping. This profile reflects an adaptive psychological pattern, in which vaginitis is appraised as a manageable condition rather than a socially discrediting illness. Individuals in this group are likely to engage more actively with healthcare services and to utilize available social and informational resources. These factors may buffer negative emotional responses and reinforce adaptive coping behaviors. From a clinical perspective, such patients may also serve as potential peer supporters, contributing to both their own resilience and that of others. Nevertheless, given the recurrent nature of vaginitis, ongoing monitoring of psychological well-being remains warranted even within this relatively low-risk group [45]. The Moderate Stigma–Conventional Coping Group, representing the largest proportion of the sample, appears to reflect a transitional psychosocial state. Individuals in this group experience a certain degree of stigma but have not yet developed stable maladaptive coping patterns. This intermediate positioning suggests a high degree of modifiability. With timely and appropriate support, these patients may shift toward more adaptive coping trajectories. Therefore, this group represents a critical window for early intervention, particularly through stigma reduction, targeted health education, and strengthening of social support [45, 46]. In contrast, the High Stigma–Negative Coping Group represents a more vulnerable and potentially self-reinforcing pattern. Elevated stigma, combined with resignation and avoidance, may create a cycle in which negative perceptions discourage help-seeking and reduce engagement with support systems. Over time, this may further intensify internalized stigma and psychological distress. As such, interventions for this subgroup should prioritize breaking this cycle through integrated strategies, including psychological support, stigma reduction, and guided coping skills training. The identified profiles can be broadly understood within established theoretical perspectives on stigma and coping. Consistent with prior frameworks [32, 33], stigma operates as a socially constructed process, while individual cognitive appraisals shape emotional and behavioral responses to illness. The present findings extend these perspectives by demonstrating how distinct combinations of stigma and coping co-occur at the individual level, forming clinically meaningful subgroups. This profile-based pattern highlights the importance of addressing both social perceptions and cognitive responses in intervention design. Influencing factors of potential profile categories of stigma and medical coping in patients with vaginitis Univariate analyses revealed significant differences in age, employment status, education level, monthly income, knowledge of vaginitis, and social support across the three latent profiles. In multivariable models, unemployment, lower disease knowledge, and reduced perceived social support remained independently associated with less favorable profiles, while older age was additionally linked to the High Stigma–Negative Coping Group. These results suggest that differences across profile categories are shaped not only by disease-related factors but also by broader social, cognitive, and interpersonal resources. The results showed that unemployed participants were more likely to fall into the Moderate Stigma–Conventional Coping Group or the High Stigma–Negative Coping Group, aligning with previous evidence linking unemployment to more negative coping strategies [47, 48]. Employment may provide access to broader psychosocial and material resources, including social participation, financial independence, and self-efficacy, which may help buffer the psychological burden associated with stigmatized conditions [49, 50]. Conversely, unemployment may be associated with financial strain, reduced social engagement, and lower perceived control, potentially contributing to more negative emotional responses and less adaptive coping. Older age was associated with a higher likelihood of belonging to the High Stigma–Negative Coping Group. This may reflect generational differences in attitudes toward reproductive and sexual health, suggesting that older women may be more likely to perceive gynecological symptoms as embarrassing and less likely to seek information or discuss such issues openly [51, 52]. Furthermore, a potential reliance on traditional rather than digital health resources, coupled with fewer opportunities for peer communication, may further contribute to this pattern. Greater knowledge of vaginitis was associated with a lower likelihood of belonging to both the Moderate Stigma–Conventional Coping Group and the High Stigma–Negative Coping Group, underscoring the protective role of disease understanding in stigma–coping patterns. It is plausible that women with greater knowledge are more likely to understand vaginitis through a biomedical lens rather than a moralized or self-blaming one. This suggests a shift toward a biomedical interpretation of the condition, which may reduce self-blame and internalized shame while promoting more adaptive coping strategies [53]. Consistent with findings from other cultural contexts, studies in Turkish populations have reported substantial knowledge gaps regarding genital hygiene and probiotic use, with incorrect practices contributing to treatment failure [54, 55]. Such deficits may not only impair treatment outcomes but also reinforce stigma, as patients without accurate biomedical understanding may attribute the condition to personal fault. In contrast, enhancing knowledge may facilitate symptom recognition, timely healthcare-seeking, and increased confidence in treatment. Perceived social support was another significant factor associated with profile categories. Women with higher social support were less likely to belong to the less favorable profiles, particularly the High Stigma–Negative Coping Group. This suggests that higher perceived social support may buffer psychological distress and facilitate adaptive coping [56]. This finding is consistent with the theoretical framework discussed above, suggesting that stigma may lead to internalized negative emotions and social withdrawal, which in turn influences coping strategies by promoting avoidance or resignation rather than active engagement. Notably, stigma and social support may interact bidirectionally, as stigma-related concealment can reduce perceived support [57]. Women who experience stronger stigma may avoid others or conceal their condition, thereby reducing their perceived social support. Although some sociodemographic variables, such as education level and monthly income, differed across profiles in univariate analyses, they were not significant in the multivariable model. Alternatively, it is possible that these variables exert indirect effects through mediating factors such as knowledge level or social support, which may explain their lack of significance in the adjusted model. This suggests that their effects may be mediated by more proximal psychosocial factors. Consequently, the absence of statistical significance after adjustment should not necessarily be interpreted as irrelevant; rather, it implies that their influence may be indirect or context dependent. Limitations This study has several limitations that warrant consideration and provide guidance for future research. Firstly, this study employed a cross-sectional design with a relatively small sample size drawn from a single Grade A tertiary general hospital, which may limit the generalizability of the findings. In addition, as data were collected at a single time point, temporal changes in stigma and coping could not be assessed, and causal relationships cannot be established. Future studies using longitudinal designs, larger samples, and multi-center settings are needed to enhance the robustness and generalizability of the findings. Secondly, convenience sampling was used to recruit participants, which may introduce selection bias. Although predefined inclusion and exclusion criteria were applied during recruitment, the sample may not fully represent the broader population of patients with vaginitis. Future studies employing probability-based sampling methods are warranted to improve representativeness. Thirdly, although the measurement tools used in this study demonstrated acceptable internal consistency, some of them have not been fully validated in populations with vaginitis, which may affect measurement accuracy. Further validation studies are needed to confirm their applicability in this specific population. Fourthly, the use of self-report questionnaires to assess stigma and coping strategies may introduce reporting bias, such as social desirability or recall bias. Future research could incorporate mixed methods, including qualitative interviews or behavioral observations, to obtain a more comprehensive understanding. Finally, several potential confounding factors, such as symptom severity, recurrence history, and treatment history, were not included in the analysis, which may have influenced the observed associations. Future studies should consider incorporating these variables to provide a more comprehensive analysis. Conclusions In conclusion, this study identified three latent profiles of stigma and medical coping among patients with vaginitis: the Low Stigma–Active Coping Group, Moderate Stigma–Conventional Coping Group, and High Stigma–Negative Coping Group. The findings demonstrate the heterogeneity of stigma and coping patterns in this population and provide a basis for more targeted intervention. Age, employment status, knowledge of vaginitis, and perceived social support were important factors associated with different profile categories. In practice, gynecologists, nurses, psychologists, and community healthcare providers should collaborate to implement stigma screening, tailored health education, and psychosocial support for different patient subgroups. In particular, patients in the High Stigma–Negative Coping Group may require more focused disease education, stigma reduction, and psychosocial support. Future studies, particularly longitudinal and intervention-based research, are needed to further explore the causal relationships and evaluate the effectiveness of targeted interventions. Supplementary Information Supplementary Material 1. Supplementary Material 2. Acknowledgements We thank all patients who participated in this study. This study was funded by the Guangdong Provincial Hospital of Traditional Chinese Medicine (Grant YN2020HL05). Authors’ contributions Study conception and design: YL, SL, HQH; Data collection: ZZJ, SL, LYS; Data analysis and interpretation: LYS, YL, ZZJ; Drafting of the article: LYS, YL. Critical review of the manuscript: HQH, SL. All the authors have carefully reviewed the article and approved the final draft. Funding This study was funded by the Guangdong Provincial Hospital of Traditional Chinese Medicine (Grant YN2020HL05). Data availability Due to the principle of scientific research confidentiality, we promised to keep participant’s information and data confidential, and the data used for this study will not be public, but available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate Participants were informed that participation was voluntary, and informed consent was obtained from all participants. The study protocol was in accordance with the ethical guidelines of the Declaration of Helsinki and was approved by the Institutional Research Board of Guangdong Provincial Hospital of Traditional Chinese Medicine (No. BF2022–130–01), and no identifying information was included in the questionnaire. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1. Supplementary Material 2. Data Availability Statement Due to the principle of scientific research confidentiality, we promised to keep participant’s information and data confidential, and the data used for this study will not be public, but available from the corresponding author on reasonable request.